These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1441746)

  • 1. Efficient selection of phleomycin-resistant Saccharomyces cerevisiae transformants.
    Wenzel TJ; Migliazza A; Steensma HY; van den Berg JA
    Yeast; 1992 Aug; 8(8):667-8. PubMed ID: 1441746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phleomycin resistance encoded by the ble gene from transposon Tn 5 as a dominant selectable marker in Saccharomyces cerevisiae.
    Gatignol A; Baron M; Tiraby G
    Mol Gen Genet; 1987 May; 207(2-3):342-8. PubMed ID: 2441230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vector YFRp1 allows transformant selection in Saccharomyces cerevisiae via resistance to formaldehyde.
    Wehner EP; Brendel M
    Yeast; 1993 Jul; 9(7):783-5. PubMed ID: 8368012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning of Saccharomyces cerevisiae promoters using a probe vector based on phleomycin resistance.
    Gatignol A; Dassain M; Tiraby G
    Gene; 1990 Jul; 91(1):35-41. PubMed ID: 1698168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autonomously replicating plasmid transforms Botrytis cinerea to phleomycin resistance.
    Santos M; Vallejo I; Rebordinos L; Gutiérrez S; Collado IG; Cantoral JM
    FEMS Microbiol Lett; 1996 Apr; 137(2-3):153-8. PubMed ID: 8998978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectable marker replacement in Saccharomyces cerevisiae.
    Vidal M; Gaber RF
    Yeast; 1994 Feb; 10(2):141-9. PubMed ID: 8203156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a transformation system for the thermophilic fungus Talaromyces sp. CL240 based on the use of phleomycin resistance as a dominant selectable marker.
    Jain S; Durand H; Tiraby G
    Mol Gen Genet; 1992 Sep; 234(3):489-93. PubMed ID: 1406595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a YAP1 overexpression cassette conferring specific resistance to cerulenin and cycloheximide as an efficient selectable marker in the yeast Saccharomyces cerevisiae.
    Akada R; Shimizu Y; Matsushita Y; Kawahata M; Hoshida H; Nishizawa Y
    Yeast; 2002 Jan; 19(1):17-28. PubMed ID: 11754479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Saccharomyces cerevisiae phleomycin-sensitive mutant, ph140, is defective in the RAD6 DNA repair gene.
    He CH; Masson JY; Ramotar D
    Can J Microbiol; 1996 Dec; 42(12):1263-6. PubMed ID: 8989864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of sulfite resistance in Saccharomyces cerevisiae as a dominant selectable marker.
    Park H; Lopez NI; Bakalinsky AT
    Curr Genet; 1999 Dec; 36(6):339-44. PubMed ID: 10654087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of in vivo (cellular) phleomycin sensitivity by nuclear genotype, growth phase, and metal ions.
    Moore CW
    Cancer Res; 1982 Mar; 42(3):929-33. PubMed ID: 6174219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct selection of Saccharomyces cerevisiae resistant to the antibiotic G418 following transformation with a DNA vector carrying the kanamycin-resistance gene of Tn903.
    Webster TD; Dickson RC
    Gene; 1983 Dec; 26(2-3):243-52. PubMed ID: 6323263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic transformation of Trametes versicolor to phleomycin resistance with the dominant selectable marker shble.
    Bartholomew K; Dos Santos G; Dumonceaux T; Charles T; Archibald F
    Appl Microbiol Biotechnol; 2001 Jul; 56(1-2):201-4. PubMed ID: 11499931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Yeast (Saccharomyces cerevisiae) secretory expression vector maintained stably in Pro3+ transformants in rich medium].
    Xie HY; Tang Y; Jiang WD; He HY; Liu M; Kuang DR
    Yi Chuan Xue Bao; 2000; 27(4):369-76. PubMed ID: 11147357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutant approach and molecular strategy to study fungal cell walls.
    Pramanik A; Martinez M; McKoy JF; Ospina R; Daly J; Moore CW
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S73-81. PubMed ID: 8574150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of Candida guilliermondii wild-type strains using the Staphylococcus aureus MRSA 252 ble gene as a phleomycin-resistant marker.
    Foureau E; Courdavault V; Simkin AJ; Sibirny AA; Crèche J; Giglioli-Guivarc'h N; Clastre M; Papon N
    FEMS Yeast Res; 2013 May; 13(3):354-8. PubMed ID: 23374647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High efficiency transformation of Tolypocladium geodes conidiospores to phleomycin resistance.
    Calmels T; Parriche M; Durand H; Tiraby G
    Curr Genet; 1991 Sep; 20(4):309-14. PubMed ID: 1934136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved protocols for functional analysis in the pathogenic fungus Aspergillus flavus.
    He ZM; Price MS; Obrian GR; Georgianna DR; Payne GA
    BMC Microbiol; 2007 Nov; 7():104. PubMed ID: 18039373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the phenotypic and genetic stability of recombinant Trichoderma spp. generated by protoplast- and Agrobacterium-mediated transformation.
    Cardoza RE; Vizcaino JA; Hermosa MR; Monte E; Gutiérrez S
    J Microbiol; 2006 Aug; 44(4):383-95. PubMed ID: 16953173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insertion of transposon Tn9 into the spinal (Escherichia coli-Saccharomyces cerevisiae) plasmids and the expression of the prokaryotic gene of chloramphenicol resistance in yeast cells].
    Fedorova IV; Kozhina TN; Peshekhonov VT; Chepurnaia OV; Zakharov IA
    Genetika; 1983 Apr; 19(4):541-7. PubMed ID: 6305766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.